Keith Zullow
FDA Approves Eli Lilly’s REZVOGLAR As the Second Interchangeable Insulin Glargine
Big Molecule Watch ·
Biosimilars Licensing Agreement Updates
Big Molecule Watch ·
Apotex Files IPR Petition on Aflibercept Patent
Big Molecule Watch ·
Update on Xbrane’s Ranibizumab Application
Big Molecule Watch ·
FDA Annual Public Meeting Regarding User Fees
Big Molecule Watch ·